Scilight Press

Author Information

Received: 27 Nov 2024 | Accepted: 29 Nov 2024 | Published: 02 Dec 2024

Abstract

Keywords

infection and autoimmunity | autoimmunity | autoantibodies | SARS-CoV-2 | COVID-19

References 

• 1.
  Mahroum, N.; Alghory, A.; Kiyak, Z.; Alwani, A.; Seida, R.; Alrais, M.; Shoenfeld, Y. Ferritin–from iron, through inflammation and autoimmunity, to COVID-19. J. Autoimmun. 2022, 126, 102778. https://doi.org/10.1016/j.jaut.2021.102778.
• 2.
  Rosario, C.; Zandman-Goddard, G.; Meyron-Holtz, E.G.; D’Cruz, D.P.; Shoenfeld, Y. The hyperferritinemic syndrome: macrophage activation syndrome, Still’s disease, septic shock and catastrophic antiphospholipid syndrome. BMC Med. 2013, 11, 185. https://doi.org/10.1186/1741-7015-11-185.
• 3.
  Mahroum, N.; Elsalti, A.; Al Shawaf, M.; Darkhabani, M.; Alwani, A.; Seida, R.; Ertas, M.T.; Simsek, A.G.; Awad, M.; Habra, M.; et al. Artificial intelligence meets the world experts; updates and novel therapies in autoimmunity–The 14th international congress on autoimmunity 2024 (AUTO14), Ljubljana. Autoimmun. Rev. 2024, 24, 103698. https://doi.org/10.1016/j.autrev.2024.103698.
• 4.
  Barzilai, O.; Sherer, Y.; Ram, M.; Izhaky, D.; Anaya, J.M.; Shoenfeld, Y. Epstein-Barr virus and cytomegalovirus in autoimmune diseases: are they truly notorious? A preliminary report. Ann. N. Y. Acad. Sci. 2007, 1108, 567–577. https://doi.org/10.1196/annals.1422.059.
• 5.
  Mahroum, N.; Elsalti, A.; Alwani, A.; Seida, I.; Alrais, M.; Seida, R.; Esirgun, S.N.; Abali, T.; Kiyak, Z.; Zoubi, M.; et al. The mosaic of autoimmunity–Finally discussing in person. The 13(th) international congress on autoimmunity 2022 (AUTO13) Athens. Autoimmun. Rev. 2022, 21, 103166. https://doi.org/10.1016/j.autrev.2022.103166.
• 6.
  Damoiseaux, J.; Dotan, A.; Fritzler, M.J.; Bogdanos, D.P.; Meroni, P.L.; Roggenbuck, D.; Goldman, M.; Landegren, N.; Bastard, P.; Shoenfeld, Y.; et al. Autoantibodies and SARS-CoV2 infection: The spectrum from association to clinical implication: Report of the 15th Dresden Symposium on Autoantibodies. Autoimmun. Rev. 2022, 21, 103012. https://doi.org/10.1016/j.autrev.2021.103012.
• 7.
  Gracia-Ramos, A.E.; Martin-Nares, E.; Hernandez-Molina, G. New Onset of Autoimmune Diseases Following COVID-19 Diagnosis. Cells 2021, 10, 3592. https://doi.org/10.3390/cells10123592.
• 8.
  Mahroum, N.; Habra, M.; Alrifaai, M.A.; Shoenfeld, Y. Antiphospholipid syndrome in the era of COVID-19–Two sides of a coin. Autoimmun. Rev. 2024, 103543. https://doi.org/10.1016/j.autrev.2024.103543.
• 9.
  Hu, B.; Huang, S.; Yin, L. The cytokine storm and COVID-19. J. Med. Virol. 2021, 93, 250–256. https://doi.org/10.1002/jmv.26232.
• 10.
  Fernandez-Cruz, A.; Ruiz-Antoran, B.; Munoz-Gomez, A.; Sancho-Lopez, A.; Mills-Sanchez, P.; Centeno-Soto, G.A.; Blanco-Alonso, S.; Javaloyes-Garachana, L.; Galan-Gomez, A.; Valencia-Alijo, A.; et al. A Retrospective Controlled Cohort Study of the Impact of Glucocorticoid Treatment in SARS-CoV-2 Infection Mortality. Antimicrob. Agents Chemother. 2020, 64, 01168-20. https://doi.org/10.1128/AAC.01168-20.
• 11.
  Li, J.; Liao, X.; Zhou, Y.; Wang, L.; Yang, H.; Zhang, W.; Zhang, Z.; Kang, Y. Comparison of Associations Between Glucocorticoids Treatment and Mortality in COVID-19 Patients and SARS Patients: A Systematic Review and Meta-Analysis. Shock 2021, 56, 215–228. https://doi.org/10.1097/SHK.0000000000001738.
• 12.
  World Health Organization. WHO COVID-19 Dashboard; World Health Organization: Geneva, Switzerland, 2024.
• 13.
  Acosta-Ampudia, Y.; Monsalve, D.M.; Rojas, M.; Rodriguez, Y.; Zapata, E.; Ramirez-Santana, C.; Anaya, J.M. Persistent Autoimmune Activation and Proinflammatory State in Post-Coronavirus Disease 2019 Syndrome. J. Infect. Dis. 2022, 225, 2155–2162. https://doi.org/10.1093/infdis/jiac017.
• 14.
  Anaya, J.M.; Herran, M.; Beltran, S.; Rojas, M. Is post-COVID syndrome an autoimmune disease? Expert Rev. Clin. Immunol. 2022, 18, 653–666. https://doi.org/10.1080/1744666X.2022.2085561.
• 15.
  Hulscher, N.; Hodkinson, R.; Makis, W.; McCullough, P.A. Autopsy findings in cases of fatal COVID-19 vaccine-induced myocarditis. ESC Heart Fail. 2024. https://doi.org/10.1002/ehf2.14680.
• 16.
  Mahroum, N.; Lavine, N.; Ohayon, A.; Seida, R.; Alwani, A.; Alrais, M.; Zoubi, M.; Bragazzi, N.L. COVID-19 Vaccination and the Rate of Immune and Autoimmune Adverse Events Following Immunization: Insights From a Narrative Literature Review. Front. Immunol. 2022, 13, 872683. https://doi.org/10.3389/fimmu.2022.872683.